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Ms. S, age 24, is referred to our team in early December by her primary care physician for
“fatigue.” The patient describes going to bed and falling asleep before 9:30 these winter
evenings, whereas in summer she went to bed at 11 PM. She craves bread, pasta, and sweets
and reports increased appetite in winter compared with summer. Her mood is low, and she
misses warm-weather activities of gardening and walking. Fatigue and difficulty concentrating
are causing her problems at work and school.
Her history reveals mood elevation in spring as days become longer, with a clear change at
approximately March 10 to 20. She reports “spring fever” and feeling “great” last year as soon
as daylight saving time began. She slept only 3 hours a night and had a burst of ideas to expand
her small business. She threw herself into her work, feeling she was making up for lost time
and productivity. She also admits to making a large, misguided business investment during
that time.
Upon questioning, she recalls that the previous spring she argued with her father and threw a
cup of hot tea at him. When interviewed, Ms. S’s mother describes her daughter at that time
as having “a very short fuse,” speaking loud and fast, staying up late at night, and looking as
though she was not herself.
Seasonal affective disorder (SAD) is an umbrella term for mood disorders that follow a seasonal
pattern of recurrence. Bipolar I disorder (BD I) or bipolar II disorder (BD II) with seasonal
pattern (BD SP) is the DSM-IV-TR diagnosis for persons with depressive episodes in the fall
or winter and mania (BD I) or hypomania (BD II) in spring or summer (Table 1, page 44).1
This article compares BD SP with major depressive disorder with seasonal pattern (MDD SP),
in which depressive episodes usually occur in fall or winter and fully remit in spring or summer.
1 Rather than being categorically distinct from each other, BD SP and MDD SP may represent
extreme variants on a seasonal depression continuum from unipolar to bipolar.
Disclosures
Drs. Roecklein and Rohan report no financial relationship with any company whose products are mentioned in this article or with
manufacturers of competing products.
Dr. Postolache received an investigator-initiated award from The LiteBook Company (Vancouver, Canada) via the Society for Light
Treatment and Biological Rhythms, as well as research support from Apollo Health (Salt Lake City, UT).
NIH Public Access
Author Manuscript
Curr Psychiatr. Author manuscript; available in PMC 2010 May 21.
Published in final edited form as:
Curr Psychiatr. 2010 February ; 9(2): 42–54.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Overlap of MDD SP and BD SP
The seasonal pattern specifier can be applied to a diagnosis of MDD, BD I, or BD II.1
Seasonality-focused assessments, described below, can help characterize seasonal patterns that
do not meet full SP criteria but may deserve clinical attention.
Symptom presentation
MDD SP and BD SP share similar atypical depressive symptom presentations and seasonal
recurrence patterns (Box 1). Hypersomnia, hyperphagia, and psychomotor retardation are more
prevalent in major depressive episodes of bipolar disorders and SAD than in unipolar or
nonseasonal mood disorders.2–4 Individuals with SAD also report fatigue and decreased
physical activity,3 both of which are characteristic of bipolar depressive episodes.5
Box 1
Seasonal affective disorder: A depression continuum from unipolar to
bipolar?
Seasonality refers to the degree of seasonal changes in behavior and mood within an
individual. Seasonality scores are normally distributed,a suggesting that seasonality may be
continuous in the general population–with some individuals meeting criteria for a seasonal
mood disorder:
• A seasonal pattern is reported by approximately 10% to 20% of depressed
outpatients with recurrent mood disorders and an estimated 15% to 22% of
individuals with bipolar disorder (BD).b
• Persons with BD–seasonal or not–report greater seasonality compared with those
with major depressive disorder (MDD).c
Among individuals with seasonal affective disorder, the course is bipolar in an estimated
12% to 22% and unipolar in 78% to 88%.d These estimates may reflect underdiagnosis of
BD with seasonal pattern because hypomania is difficult to diagnose retrospectively.e
The bipolar-unipolar continuum includes (in order): BD I, BD II, bipolar disorder not
otherwise specified, cyclothymia, bipolar spectrum disorder, and MDD.f In examining the
validity of the bipolar spectrum model, Phelps et alg noted:
• At least 3 studies found that all symptoms reported by individuals with unipolar
and bipolar diagnoses approach a normal distribution, rather than a bimodal
distribution separating unipolar from bipolar symptom profiles.
• Data from 2 population-based studies indicate that subthreshold hypomanic
symptoms are more common than and cause as much impairment as symptoms
meeting criteria for BD II or I.
Some individuals who meet criteria for MDD with seasonal pattern have summertime
periods of transient hypomania and hyperthymia (hypomanic-like periods without clinically
significant impairment).h This suggests that the bipolar continuum also may exist among
individuals with seasonal pattern mood disorders.
Source:For reference citations, see this article at CurrentPsychiatry.com
Although psychosis and psychiatric hospitalizations are more common in BD I than unipolar
disorders,6 individuals with BD SP are less likely to report psychosis than those with
nonseasonal BD.7 Another study found that BD SP patients reported a higher rate of psychiatric
hospitalizations than MDD SP patients (28% vs 9.4%).6
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Recurrence pattern
Major depressive episodes are highly recurrent in both MDD and BD, with or without a
seasonal pattern. Approximately 75% of individuals with MDD experience ≥1 recurrence
(mean, 10.8 episodes);8 MDD SP patients report a mean of 13.4 episodes.9 The mean lifetime
episodes in BD SP is 20.74, compared with 11.67 in nonseasonal BD.7
Cassidy and Carroll10 measured the frequency of mood episodes in 304 BD patients not
assessed for seasonality. Manic episodes peaked in early spring, mixed episodes peaked in late
summer or fall, and depressive episodes peaked in fall-winter.
Irregular rhythm
Both BD and MDD SP involve irregularities in daily or circadian rhythms, such as changes in
the timing of sleep, melatonin release, and body temperature.3,5,11 Circadian phase delays—
in which internal rhythms lag behind the sleep cycle—are correlated with symptom severity
in BD12 and are implicated in the core pathology of BD13 (Box 2, page 46). In BD, life events
that change social rhythms may disrupt circadian rhythms, triggering mood episodes.5
Box 2
Proposed mechanisms for seasonal affective disorder
Etiologic hypotheses of seasonal affective disorder (SAD) include:
• photoperiodic hypothesis (shorter winter days cause SAD,a perhaps mediated by
a summer vs winter difference in duration of nightly melatonin release)b
• phase shift hypothesis (less available light in winter may lead to an inability to
synchronize circadian rhythms with sleep/wake rhythms).c
Some case studies of rapid-cycling bipolar disorder (BD) suggest that mood is correlated
with daily hours of sunshine and light therapy is antidepressant. Rapid-cycling patients may
be hypersensitive to day-to-day changes in photoperiod, analogous to mood changes in
response to changes in photoperiod across the seasons in SAD.d
Circadian phase delays–in which internal rhythms lag behind the sleep cycle–are
correlated with symptom severity in BDe and are implicated in the core pathology of
BD.f Phase delays also are present in some individuals with SAD and are associated with
severity and treatment response.g Preliminary evidence suggests that variation in circadian
clock genes is related to both BDf,h and SAD.i
Source:  For reference citations, see this article at CurrentPsychiatry.com
Etiologic hypotheses for both BD and SAD propose that an external event (life stress in BD;
decreased photoperiod in SAD) leads to circadian dysregulation and, in turn, mood episodes.
Circadian-related hypotheses for SAD and BD are supported by evidence showing efficacy of
treatments that manipulate behavioral and circadian rhythms.
Seasonal pattern revealed—Ms. S was aware that she is vulnerable to depressive episodes
in fall and winter but unaware of a pattern of hypomanic/manic episodes in spring and summer.
Her family psychiatric history includes a sister diagnosed with BD I (with no seasonal
specifier), and a maternal aunt who has attempted suicide several times.
Ms. S agrees to an assessment plan including a diagnostic interview, interviews measuring
symptom severity and pattern of recurrence, routine laboratory examination, and self-report
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questionnaires. These show that she meets DSM-IV-TR criteria for BD I, depressed, moderate,
with seasonal pattern.
Her assessment scores are 28 on the Structured Interview Guide for HDRS-seasonal affective
disorder version (SIGH-SAD), 17 on the Hamilton Depression Rating Scale (HDRS), and 11
on the atypical subscale. The HDRS and atypical subscale are components of the SIGH-SAD
reflecting typical (eg, insomnia, loss of appetite, etc.) and atypical (eg, hypersomnia, increased
appetite, etc.) depression symptoms, respectively. Ms. S’s scores exceed the threshold scores
defining a BD SP episode (>20 SIGH-SAD + >10 HDRS + >5 atypical sub-scale14). Data from
self-report questionnaires corroborate this assessment.
We plan to administer the Hypomania Interview Guide (including Hyperthymia) for Seasonal
Affective Disorder (HIGH-SAD) during treatment and the following spring to monitor
prospectively for hypomanic symptoms.
Assessment tools
After complete assessment for mood episodes and mood disorders based on DSM-IV-TR, an
additional assessment for bipolarity and seasonality may be helpful.1
Screen for bipolarity in patients with SAD to avoid triggering mania or hypomania during
treatment. Useful tools include:
• HIGH-SAD15
• the National Institutes of Health Life Chart Method to establish a recurrent pattern of
mood episodes and track treatment efficacy16
• assessments that characterize subthreshold bipolar symptoms, such as the Bipolar
Spectrum Diagnostic Scale17 (see Box 3 with this article at CurrentPsychiatry.com)
and the Bipolarity Index.18
Box 3
Bipolar Spectrum Diagnostic Scale
INSTRUCTIONS: Please read through the entire passage below before filling in any
blanks.
Some individuals notice that their mood and/or energy levels shift drastically from time to
time______. These individuals notice that, at times, their mood and/or energy level is very
low, and at other times, very high______. During their “low” phases, these individuals often
feel a lack of energy; a need to stay in bed or get extra sleep; and little or no motivation to
do things they need to do______. They often put on weight during these periods______.
During their low phases, these individuals often feel “blue,” sad all the time, or
depressed______. Sometimes, during these low phases, they feel hopeless or even
suicidal______. Their ability to function at work or socially is impaired______. Typically,
these low phases last for a few weeks, but sometimes they last only a few days______.
Individuals with this type of pattern may experience a period of “normal” mood in between
mood swings, during which their mood and energy level feels “right” and their ability to
function is not disturbed______. They may then notice a marked shift or “switch” in the
way they feel______. Their energy increases above what is normal for them, and they often
get many things done they would not ordinarily be able to do______. Sometimes, during
these “high” periods, these individuals feel as if they have too much energy or feel
“hyper”______. Some individuals, during these high periods, may feel irritable, “on edge,”
or aggressive______. Some individuals, during these high periods, take on too many
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activities at once______. During these high periods, some individuals may spend money in
ways that cause them trouble______. They may be more talkative, outgoing, or sexual
during these periods______. Sometimes, their behavior during these high periods seems
strange or annoying to others______. Sometimes, these individuals get into difficulty with
coworkers or the police during these high periods______. Sometimes, they increase their
alcohol or non-prescription drug use during these high periods______.
Now that you have read the passage, please check 1 of the following 4 boxes:
❏ This story fits me very well, or almost perfectly
❏ This story fits me fairly well
❏ This story fits me to some degree, but not in most respects
❏ This story doesn’t really describe me at all
Now please go back and put a check (✓) after each sentence that definitely describes
you.
For the clinician
SCORING: Each sentence checked is worth 1 point. Add 6 points for “fits me very well,”
4 points for “fits me fairly well,” and 2 points for “fits me to some degree.”
Score Likelihood of bipolar disorder
0–6 Highly Unlikely
7–12 Low Probability
13–19 Moderate Probability
20–25 High Probability
Optimum threshold for positive diagnosis: score of 13 or above
Source: Reprinted from Ghaemi SN, Miller CJ, Berv DA, et al. Sensitivity and specificity
of a new Bipolar Spectrum Diagnostic Scale. J Affect Disord. 2005;84:273-277, with
permission from Elsevier
Also obtain collateral reports from significant others, review patient records, and use the same
mania and hypomania scales for prospective assessment as the next spring approaches.6
Assess seasonality in patients with BD to improve diagnosis and treatment. Characterizing
a seasonal pattern may allow you and your patient to predict episodes and treat proactively.
Commonly used assessments include the SIGH-SAD and the Structured Clinical Interview for
DSM Disorders (SCID) seasonal pattern specifier module.19
The SIGH-SAD measures symptom severity and provides recovery criteria based on changes
in scores during treatment. Response is defined as a 50% reduction in symptoms; remission is
>50% improvement in SIGH-SAD + HDRS <7 + atypical <7 or HDRS <2 + atypical <10.14
Treatment begins
Considering Ms. S’s diagnosis of BD I SP and the risk of precipitating mania with light
treatment, we recommend starting treatment with a mood stabilizer. We narrow our options to
those that have a direct antide-pressant effect, with the hope that this may reduce the need for
future antidepressant medications. For patients diagnosed with BD II SP, we could consider a
regimen without mood stabilizers.
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We offer Ms. S lithium, a first-line mood stabilizer with evidence of usefulness in treatment
before chronotherapeutic interventions and in preventing suicidal behavior. However, Ms. S
prefers our second option, lamotrigine, because she is concerned about lithium’s side effects
and required blood draws to check drug levels as well as thyroid and kidney status.
Despite causing some initial drowsiness, her lamotrigine dosage is successfully titrated after
2 weeks of treatment to 300 mg/d, without side effects. Only then do we initiate light treatment,
which Ms. S wishes to try before antidepressant medications. She also begins sessions with a
therapist trained in cognitive-behavioral therapy (CBT) for SAD. (For details of this
comprehensive treatment, see the online-only Box 4 in this article at CurrentPsychiatry.com)
Box 4
Light therapy and CBT for bipolar disorder with seasonal pattern
Bright light therapy is effective in treating major depressive disorder with seasonal pattern
(MDD SP), and initial reports indicate that light also can improve depressive symptoms in
bipolar disorder with seasonal pattern (BD SP).a In an early case report,b a patient with BD
II SP achieved remission of a depressive episode with a 4-day open trial of 2,000 lux of
fluorescent light given daily between 6 and 9 AM and 4 and 7 PM.
An open trialc compared the effects of 10,000 lux of fluorescent light for 30 minutes in early
morning on 21 patients with BD SP and 170 patients with MDD SP. The BD SP participants
were more depressed at baseline, but improved significantly as measured by the Structured
Interview Guide for HDRS-seasonal affective disorder version (SIGH-SAD). Response
rates were similar, and the BD SP patients tolerated light therapy well.
A third open study of 74 unipolar and 18 bipolar participants initially administered 2,500
lux of light for 2 hours in the morning. After 2 years of the study, subsequent participants
received 10,000 lux for 30 minutes in the morning or evening (crossover design). Response
rates for both light paradigms were 73% among those with MDD SP vs 50% among those
with bipolar disorder, although the small number of bipolar participants limits the ability
to draw conclusions.d
Risk of switching. Light therapy may increase the risk of switching to mania/hypomania
in patients with BD SP. Clinical supervision is imperative, therefore, even for patients
thought to have MDD SP because of the risk of undiagnosed BD.
CASE REPORT
Light therapy plus CBT
Because of Ms. S’s diagnosis of BD I, depressed, moderate, with seasonal pattern, we start
therapy with the mood stabilizer lamotrigine, titrated across 2 weeks to 300 mg/d without
side effects. Then, to treat her depressive symptoms, Ms. S prefers to try light therapy instead
of an antidepressant.
We start Ms. S’s therapy with a light box in the office for 10 minutes at midday. A low dose
and midday administration reduce the potential for a mood switch in BD I patients. We
assess Ms. S’s mood, rate of speech and thinking, and side effects after the session.
Afterwards, she purchases a light box for home use, at first for 5 to 10 minutes each morning
then titrated within 7 days to 20 minutes in the morning. Her husband is educated to watch
for signs of hypomania. A nurse phones Ms. S twice the first week to assess for side effects
and possible signs of hypomania/mania. Phone monitoring includes sleep onset, sleep offset,
duration of sleep, and rate of speech.
Ms. S returns after 2 weeks for assessment. We administer the HIGH-SAD for symptoms
of hypomania and SIGH-SAD for response to light therapy. Ms. S reports increased energy
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and improved mood. She agrees to continue light therapy 20 minutes each morning and to
come back for additional assessment in 4 weeks.
We also refer Ms. S for 6 weeks of twice-weekly sessions of cognitive-behavioral therapy
(CBT) for SAD. The therapist focuses on cognitive restructuring, behavioral activation, and
relapse prevention. Ms. S has always thought “I’m no use in the winter.” Through therapy,
she discovers she can be moderately productive in winter if she paces herself, and her mood
improves when she is productive.
Behavioral activation strategies include modifying Ms. S’s summer-specific activities for
winter (such as walking in the mall and volunteering at the botanical gardens). Ms. S’s
consistency in engaging in these activities proves to be key in maintaining a euthymic mood
in winter.
Considering Ms. S’s BD I diagnosis, the therapist emphasizes keeping regular daily
schedules, especially at times of stress and increased work or academic tasks.
Encouraging compliance. Patients often complain about lack of time for light therapy as
recommended. We suggest that they use therapy time to read, pay bills, or return phone
calls. Light treatment can be viewed as increasing productivity and quality of life, instead
of taking away 30 minutes or more.
We also find better compliance and outcomes when the duration and timing of light
treatment is flexible and frequently changes, compared with a fixed duration changed every
2 weeks or so. A flexible schedule takes into account clinical response, potential shifting
in sleepiness and alertness, and side effects.
References
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disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005;162(4):656–662.
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Treating bipolar variant of SAD
Significant differences exist in the clinical management of BD SP and MDD SP, despite their
commonalities (Table 2). BD SP treatment remains distinct because of the risk of switching
with the use of light therapy or antidepressants and the importance of mood stabilizers,
especially in BD I.
Consensus guidelines for treating SAD recommend mood stabilizers and close monitoring
during light therapy for patients with BD SP (Table 3, page 48).2 Therapeutic sleep deprivation
can quickly reverse depression during hospitalization but is not used often or recommended
for outpatient treatment.20
Light therapy
A small body of evidence suggests that depressive symptoms in BD SP improve with bright
light therapy, a treatment with demonstrated efficacy in MDD SP.21 No differences in response
have been reported between light therapy for winter depressive episodes among individuals
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with BD SP or MDD SP.22–24 Light therapy may increase the risk of switching to mania/hypo
mania in patients with BD SP, however. Clinical supervision is imperative, even for patients
thought to have MDD SP, because of the risk of undiagnosed BD.
Regular monitoring by a physician is indicated for individuals taking medications or remedies
with photosensitizing effects (such as lithium, thioridazine, or St. John’s wort). An
ophthalmologist consultation and monitoring is necessary for patients with preexisting eye
problems, those taking photosensitizing medications, and those who develop eye problems
during light treatment.2,6
The recommended starting dose for light therapy in MDD SP is 30 minutes daily in the early
morning, but this dose may be too high for individuals with BD SP.25 To minimize the risk of
switching, begin light therapy at 5 to 10 minutes daily and slowly increase while monitoring
the clinical effect (see Related Resources, page 53, for more information about light therapy
for affective disorders).
Pharmacotherapy
Pharmacologic treatments have not been studied for effectiveness in BD SP, and we hesitate
to provide specific recommendations. Effective treatments may include those used for
nonseasonal MDD, nonseasonal BD, and MDD SP. When using any medication for BD SP,
weigh the risk of switching states against the potential beneficial effects.2
Year-round mood-stabilizer treatment is indicated to minimize the risk of mood episodes in
BD SP, especially in patients with BD I. When treating SAD, mood stabilizers with
antidepressant effects—such as lamotrigine or lithium (for maintenance), and quetiapine or
aripiprazole (for acute treatment)—are preferable to agents without an antidepressant effect in
monotherapy. More-sedating mood stabilizers (such as valproate or carbamazepine) likely
would not be as beneficial as less-sedating agents, considering that patients with SAD
frequently experience fatigue.
Because of the lack of adequate clinical trials of treatments for BD SP, we suggest that clinicians
choose medications and follow algorithms relevant to BD without a seasonal specifier. Use
similar schedules and dosages, with individual tailoring.5,26
Antidepressants that have shown efficacy in MDD SP include fluoxetine, bupropion,
citalopram, and sertraline.6,9,27–29 For patients with BD SP, we initiate antidepressants when:
• light treatment fails
• the patient is unable to travel to the south
• light treatment is not available (often because patients cannot afford the cost, which
is not covered by insurance)
• patient lacks time for light treatment.
An additional important consideration is history of response (such as a patient who did not
respond well to light therapy in the past but responded very well to a particular antidepressant).
No studies have compared antidepressant classes or individual medications for MDD SP.
Clinical wisdom is to base the antidepressant choice, dosages, decision points of when to
switch, and schedule of switching (cross-tapering) on individual patients’ symptom clusters
and comorbid conditions as well as the medication’s side effects.
Prophylactic treatment with bupropion would seem an appropriate initial choice for a
prototypical SAD patient, considering this medication’s more activating effects and FDA
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approval for SAD treatment.9 For the minority of patients with SAD who present with agitation
and increased sleepiness, a slightly sedating selective serotonin reup-take inhibitor such as
citalopram would make more sense as a first-line treatment. Finally, we would recommend
sertraline for patients with marked anxiety—especially panic attacks or obsessive-compulsive
symptoms—but without insomnia.
For specific dosages, rely on the literature of treating nonseasonal depression (unipolar or
bipolar). It is important to define decision-making points for dosage increases, augmentation,
switching to another antidepressant, and cross-tapering, similar to how you would address a
nonseasonal depression, typical or atypical.
In our view, treating a patient with BD I SP with an antidepressant alone—without a mood
stabilizer—is almost always wrong. For BD II SP we leave it to the clinician to decide, based
on individual patients, clinical experience, and ideally in consultation with a peer.
Seasonal dosages
You may wish to seasonally vary medications and dosages for patients with BD SP. Although
no strong evidence exists, we recommend 2 options:
• Consider increasing mood-stabilizing medication in spring and summer, with a
reduction (but no tapering for BD I) in fall and winter.
• Consider a complete antidepressant taper 2 weeks after daylight saving time begins
in spring; taper under increased observation and not faster than 6 weeks, with close
attention to emerging symptoms of depression or antidepressant withdrawal.
We do not taper antidepressants before daylight saving time, and we always consider additional
stressors, losses, and challenges in our patients’ lives before tapering antidepressants in spring
or summer. We also assess and monitor compliance.
Psychotherapy
Referral can be made to clinicians trained in CBT for patients with a seasonal pattern and
interpersonal and social rhythm therapy (IPSRT) for BD. Integrative models for SAD and BD
propose that psychological and biologic vulnerability factors interact with environmental
events (such as winter season or disruption of daily routine) to trigger mood episodes.
CBT adapted for SAD targets mal-adaptive thinking and behavioral disengagement through
cognitive therapy and behavioral activation to counteract SAD symptoms.30,31 Preliminary
trials by our group suggest that CBT for MDD SP is an effective acute treatment30 and may
prevent future episodes.32 IPSRT is an adaptation of interpersonal psychotherapy that aims to
stabilize social relationships and rhythms in BD.33
IPSRT posits that irregularity in daily routines leads to circadian dysregulation, precipitating
mood episodes in persons vulnerable to BD.34 The degree of regularity in social rhythms
achieved in IPSRT is associated with reduced likelihood of recurrence post-treatment.34 If
stabilizing social rhythms has a similar effect of regulating circadian rhythms in SAD, IPSRT
may be effective in treating BD SP.
Ongoing treatment required
After several months of light therapy, Ms. S begins to feel better and reports having more
energy. We taper her light therapy to 10 minutes daily in the morning from late February until
1 week after daylight saving time begins in mid-March. Weekly phone calls during this
transition screen for signs of hypomania or mania. Lamotrigine is effective in preventing
switches in spring.
Roecklein et al. Page 9
Curr Psychiatr. Author manuscript; available in PMC 2010 May 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Future plans include monitoring for hypomania through summer and possibly reinitiating light
therapy in fall or winter. Because approximately one-half of individuals who undergo CBT for
SAD do not experience another episode the winter after treatment, light therapy will be initiated
only if depressive symptoms emerge. A booster session is scheduled with Ms. S’s CBT
therapist in early fall to reinforce relapse prevention skills.
Antidepressant therapy will be recommended if full treatment response is not maintained with
light therapy and continued use of CBT skills for SAD. During sessions, we emphasize
compliance with lamotrigine. On several occasions Ms. S questions the need for ongoing
therapy, but with education about the potential effects of mania she agrees to continue treatment
as indicated.
Related Resources
Seasonality screening tools
• Seasonal Pattern module of the Structured Clinical Interview for DSM Disorders
(SCID). www.scid4.org/faq/clinician_version.html.
• Hypomania Interview Guide for Seasonal Affective Disorder (HIGH-SAD).
www.chronotherapeutics.org/Tools_ENG.html.
• National Institutes of Health Life Chart Method.
www.bipolarnews.org/Clinician%20Life%20Charting.htm.
• Structured Interview Guide for the Hamilton Depression Rating Scale—Seasonal
Affective Disorder Version (SIGH-SAD).
www.chronotherapeutics.org/Tools_ENG.html.
Bipolarity screening tools
• Bipolar Spectrum Diagnostic Scale. Available for download with this article at
CurrentPsychiatry.com.
• Bipolarity Index. http://psycheducation.org/depression/STEPBipolarityIndex.htm.
Light therapy
• Wirz-Justice A, Benedetti F, Terman M. Chronotherapeutics for affective disorders:
a clinician’s manual for light and wake therapy. Basel, Switzerland: S. Karger AG;
2009.
• Wirz-Justice A, Benedetti F, Berger M, et al. Chronotherapeutics (light and wake
therapy) in affective disorders. Psychol Med. 2005;35(7):939–944.
Psychotherapy
• Rohan KJ. Coping with the seasons: a cognitive-behavioral approach to seasonal
affective disorder (therapist guide). New York, NY: Oxford University Press; 2008.
• Frank E. Treating bipolar disorder: a clinician’s guide to interpersonal and social
rhythm therapy. New York, NY: Guilford Press, Inc.; 2005.
Drug Brand Names
Aripiprazole • Abilify Lithium • Eskalith, Lithobid
Bupropion • Wellbutrin XL Quetiapine • Seroquel
Carbamazepine • Tegretol Sertraline • Zoloft
Citalopram • Celexa Thioridazine • Mellaril
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Fluoxetine • Prozac Valproate • Depakote
Lamotrigine • Lamictal
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Table 1
DSM-IV-TR criteria for seasonal pattern specifier*
A A regular pattern of major depressive episodes (MDEs) at a particular time
of year (such as fall and/or winter)
B Full remission or change to mania or hypomania at a particular time of year
(such as spring or summer)
C 2 seasonal MDEs that followed the pattern described in (A) and (B) occurred
in the past 2 years (and no nonseasonal MDEs)
D Seasonal MDEs substantially outnumber nonseasonal MDEs across the
lifespan
Cases do not meet criteria if:
• seasonal episodes have not been present in the past 2 consecutive winters because individuals have been successfully treated or have
lived or traveled in southern locations, despite the expectation that continuing treatment is needed and/or a return to northern locales
would precipitate another seasonal episode
• an obvious psychosocial stressor related to the mood change recurs on a seasonal basis (such as regular winter unemployment, holiday
depression, anniversary reactions)
*
Can be applied to a pattern of major depressive episodes in bipolar I disorder, bipolar II disorder, or major depressive disorder
Source: Adapted from reference 1
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Table 2
Physiopathologic findings and clinical management for SAD vs BD
SAD BD
Differences May be unipolar or bipolar
Defined by seasonality
Light therapy and antidepressants indicated
Increased risk of psychosis and psychiatric hospitalization
Most BD is not seasonal
Mood stabilizers indicated
Risk of switching states with light therapy and antidepressants
Similarities Atypical depressive symptom presentation
Highly recurrent
Predictable season of recurrence allows proactive treatment
Assess for mania and hypomania in both disorders
Light therapy requires clinical supervision
Psychotherapy may be beneficial
BD: bipolar disorder; SAD: seasonal affective disorder
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Table 3
Recommended treatment for bipolar disorder with seasonal pattern
Treatment Recommendation
Mood-stabilizing medications Maintain year-round, especially in patients with BP I
Antidepressants Consider those with efficacy in unipolar SAD or nonseasonal bipolar depression
Light therapy Initiate for 5 to 10 min/day for bipolar depressive episodes in patients receiving mood stabilizers or atypical
antipsychotics; slowly increase duration while monitoring mood, sleep, and side effects to manage risk of
hypomanic or manic switch
Psychotherapy Consider CBT or interpersonal and social rhythm therapy to help manage symptoms and reduce episode
recurrence
BP I: bipolar disorder type I; CBT: cognitive-behavioral therapy; SAD: seasonal affective disorder
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